Navigation Links
K94 Discoveries, Inc. Announces Seed Financing To Advance Targeted Drug Conjugates To Treat Pancreatic And Other Cancers
Date:9/24/2013

BATON ROUGE, La., Sept. 24, 2013 /PRNewswire/ -- K94 Discoveries, Inc., (K94) a new biotechnology company applying hormone receptor-targeting technology to develop novel cancer therapies, today announced that it has closed a $300,000 seed financing. The financing was provided by BVM Capital, LLC, through its Themelios Ventures II, LP fund.  Ross P. Barrett, Managing Partner of BVM Capital, is interim President of the new company.

K94 Discoveries is developing cancer therapies based on proprietary hormone receptor-targeting discoveries by scientific founder William Hansel, Ph.D., a Professor at the William Hansel Cancer Prevention laboratory at the Pennington Biomedical Research Center of Louisiana State University (LSU). Dr. Hansel found that the luteinizing hormone-releasing hormone (LHRH) receptors present in large numbers on the surface of a wide variety of cancer cells can be harnessed to target cancer drugs.  A version of this technology is also embodied in the targeted cancer drugs being developed by Esperance Pharmaceuticals, a clinical-stage company partly based on Dr. Hansel's inventions

K94 researchers are using a similar approach to develop targeted drug conjugates by combining LHRH with the naturally-occurring plant extract curcumin, which has attracted interest as a potential anticancer agent for decades.  Preclinical studies indicate that curcumin exhibits multiple anticancer properties, and in laboratory tests it promotes cancer cell death and slows the growth of tumors.  However, curcumin's therapeutic potential has been limited by its poor solubility, which the company's novel drug conjugates are designed to overcome.  K94 is initially focusing on pancreatic cancer and is also conducting research in ovarian and breast cancer.

"We are fortunate in Louisiana to have access to extraordinary scientists such as Dr. Hanse
'/>"/>

SOURCE K94 Discoveries, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... NEWPORT NEWS, Va. , Aug. 3, 2015 ... will be joining Orthopaedic & Spine Center ... help them to manage their chronic pain through ... Dr. Robinson is a Fellowship-trained, certified medical ... and pain medicine. His vast experience ranges from ...
(Date:8/3/2015)... SINGAPORE , Aug. 3, 2015 ... Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a ... today announced financial results for its first fiscal ... Quarter Highlights and Recent Developments: ... progress in improving its cost structure, driven by ...
(Date:8/3/2015)... , Aug. 3, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... host its Second Quarter 2015 Investor Conference Call and ... The call will cover an update on ... quarter 2015 financials. A press release detailing the information ... the afternoon of Monday, August 10. Investors and the ...
Breaking Medicine Technology:Orthopaedic & Spine Center Introduces New Pain Psychologist 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 3Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 4Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 6Merrimack Pharmaceuticals Announces Timing of Second Quarter 2015 Investor Conference Call 2
... BELGRADE, Mont., July 26, 2011 Bacterin ... a leader in the development of revolutionary bone graft material ... call on Thursday, August 11, at 4:30 p.m. Eastern time ... 2011. Financial results will be issued in a press release ...
... America, Inc. today announced plans to debut expanded software ... EasyCell® assistant Automated Cell Imaging Analyzer during ... Conference and Clinical Lab Expo July 24 - 28 ... hematology portfolio can be seen at Sysmex,s exhibit booth, ...
Cached Medicine Technology:Bacterin Sets Second Quarter 2011 Conference Call for Thursday, August 11, 2011 at 4:30 p.m. ET 2Sysmex America to Debut Expanded Software Products for Middleware and Cell Image Analysis at AACC 2011 2
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... ... global insurance brokerage firm, announced today that Joe Williams has joined its growing ... sales, and delivering HUB's differentiated service model to his clients. Mr. Williams will ...
(Date:8/3/2015)... Portland, Ore. (PRWEB) , ... August 03, 2015 ... ... President of Government Programs, with accountability for overall performance of the company’s Medicare ... a key focus of Cambia’s strategy to deliver better health for members. In ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... management and investigative services, has introduced a new logo and comprehensive brand ... that improve business outcomes for its customers. EMSI’s new tagline, “Powerful Information. ...
(Date:8/3/2015)... ... , ... Did you know that there are thousands of Seniors or ... care options which A-1 Home Care Agency specialize in? In fact, diversity, multi-cultural, financing ... Home Care Agency is known for. , With all the Los ...
(Date:8/2/2015)... ... August 03, 2015 , ... Career Step, an ... at the Association for Healthcare Documentation Integrity’s (AHDI) conference being held in Alexandria, ... the opportunity the AHDI conference provides us to interact with those in the ...
Breaking Medicine News(10 mins):Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 3Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2
... ANN ARBOR, Mich. A study led by researchers at ... studies that new cancer drug compounds they developed shrank tumors, ... mouse models of human cancer, looked at two compounds designed ... p53, is inactivated in a significant number of human cancers. ...
... Scientists want to protect the optic nerve when the eye ... It,s called traumatic optic nerve damage when the fragile, spaghetti-sized ... in swelling and inflammation that can destroy its major component ... "The optic nerve is not completely straight so it can ...
... named Takeo Kanade, the U.A. and Helen Whitaker University ... University, the 2010 winner of the ACM/AAAI Allen Newell ... robotics. , The Newell Award, named for one of ... Science, recognizes career contributions that have breadth within computer ...
... to ban lead-based ammunition as a potential health and ... prime alternative material for bullets tungsten may ... that tungsten accumulates in major structures of the immune ... Research in Toxicology . Jose Centeno and colleagues ...
... ORLANDO, FL (April 6, 2011) Breast cancer is the ... women diagnosed each year. Being exposed to estrogen over a ... a woman,s risk of developing the disease. One way ... the breast cancer drug tamoxifen, which interferes with the activity ...
... be compatible with current beauty ideals, but, to a certain degree, ... However, it is a different matter if the organism stores fat ... a clear sign of a metabolic disorder. Up to ... regarded a typical characteristic of the dangerous metabolic syndrome. Deposition of ...
Cached Medicine News:Health News:Better treatment sought for blinding traumatic optic nerve damage 2Health News:CMU's Takeo Kanade wins ACM/AAAI Award for career contributions to computer vision, robotics 2Health News:Fox Chase researchers find that fish oil boosts responses to breast cancer drug tamoxifen 2Health News:Fatty liver -- how a serious problem arises 2
For the quantitative determination of Iron and IBC in serum. Colorimetric method utilizing ferrozine. Endpoint procedure measured at 560 nm. Linearity: 500 ug/dl....
HDL Cholesterol (PEG) Precip. Reagent + 5 ml of 50 mg/dl cholesterol std....
Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol...
... Intended for the quantitative ... plasma. Two vials, dry ... alphaketoglutarate. Uses NADPH to ... plasma compounds. Reaction: Enzymatic, ...
Medicine Products: